Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Diagnostics (Basel, Switzerland)
|
May 27, 2023
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
Elisabetta Zanatta, Andrea Martini, Roberto Depascale, et al.
Rheumatology (Oxford, England)
|
April 28, 2021
Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis
Margherita Zen, Enrico Fuzzi, Marta Loredo Martinez, et al.
Rheumatology (Oxford, England)
|
April 17, 2025
Unsupervised machine learning identifies distinct systemic lupus erythematosus patient endotypes with differential response to belimumab
Roberto Depascale, Raffaele Da Mutten, Julius Lindblom, et al.
Frontiers in Immunology
|
December 15, 2025
Efficacy of anifrolumab on skin, joint and lung involvement in anti-MDA5 positive dermatomyositis: a case report
Federico Pettorossi, Laura Brischigliaro, Marisol Bracalenti, et al.
Clinical and Experimental Rheumatology
|
August 5, 2022
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort
Michela Gasparotto, Sara Bindoli, Roberto Padoan, et al.
Clinical and Experimental Rheumatology
|
December 3, 2024
Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies
Elisabetta Zanatta, Beatrice Moccaldi, Andrea Martini, et al.
Frontiers in Immunology
|
November 3, 2025
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literature
Roberto Depascale, Anna Ghirardello, Elisabetta Zanatta, et al.
Journal of Autoimmunity
|
May 24, 2024
Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsets
Chiara Franco, Alessandra Giannella, Michela Gasparotto, et al.
Kidney International Reports
|
May 20, 2024
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis
Mariele Gatto, Giulia Frontini, Marta Calatroni, et al.
Kidney International Reports
|
May 20, 2024
Corrigendum to "Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 1047-1056]
Mariele Gatto, Giulia Frontini, Marta Calatroni, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Diagnostics (Basel, Switzerland)
|
May 27, 2023
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
Elisabetta Zanatta, Andrea Martini, Roberto Depascale, et al.
Rheumatology (Oxford, England)
|
April 28, 2021
Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis
Margherita Zen, Enrico Fuzzi, Marta Loredo Martinez, et al.
Rheumatology (Oxford, England)
|
April 17, 2025
Unsupervised machine learning identifies distinct systemic lupus erythematosus patient endotypes with differential response to belimumab
Roberto Depascale, Raffaele Da Mutten, Julius Lindblom, et al.
Frontiers in Immunology
|
December 15, 2025
Efficacy of anifrolumab on skin, joint and lung involvement in anti-MDA5 positive dermatomyositis: a case report
Federico Pettorossi, Laura Brischigliaro, Marisol Bracalenti, et al.
Clinical and Experimental Rheumatology
|
August 5, 2022
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort
Michela Gasparotto, Sara Bindoli, Roberto Padoan, et al.
Clinical and Experimental Rheumatology
|
December 3, 2024
Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies
Elisabetta Zanatta, Beatrice Moccaldi, Andrea Martini, et al.
Frontiers in Immunology
|
November 3, 2025
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literature
Roberto Depascale, Anna Ghirardello, Elisabetta Zanatta, et al.
Journal of Autoimmunity
|
May 24, 2024
Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsets
Chiara Franco, Alessandra Giannella, Michela Gasparotto, et al.
Kidney International Reports
|
May 20, 2024
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis
Mariele Gatto, Giulia Frontini, Marta Calatroni, et al.
Kidney International Reports
|
May 20, 2024
Corrigendum to "Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 1047-1056]
Mariele Gatto, Giulia Frontini, Marta Calatroni, et al.
Page
of 3